Owner Sloan-Kettering Institute for Cancer Research

Inventors Marks, Paul A.; Sgouros, George; Rifkind, Richard A.; Richon, Victoria M.

Agent Cullen & Co

Pub. Number AU-B-2003226408

PCT Number PCT/US03/11812

PCT Pub. Number WO2003/088954

Priority 60/373,033 15.04.02 US

Filing date 15 April 2003

Wipo publication date 3 November 2003

Acceptance publication date 14 June 2007

A61N 5/10 (2006.01) Radiation therapy - X-ray therapy

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61K 31/164 (2006.01) - of a carboxylic acid with an aminoalcohol, e.g. ceramides

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/18 (2006.01) - Sulfonamides

A61K 31/19 (2006.01)

A61K 31/195 (2006.01)

A61K 31/277 (2006.01)

A61K 31/336 (2006.01) - having three-membered rings, e.g. oxirane, fumagillin

A61K 31/4045 (2006.01)

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61K 31/473 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines

A61K 31/7028 (2006.01) - Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents